The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
MR Imaging Radiomics Signatures for Predicting the Risk of Breast Cancer Recurrence as Given by Research Versions of MammaPrint, Oncotype DX, and PAM50 Gene Assays
Open accessAbstract
Purpose To investigate relationships between computer-extracted breast magnetic resonance (MR) imaging phenotypes with multigene assays of MammaPrint, Oncotype DX, and PAM50 to assess the role of radiomics in evaluating the risk of breast cancer recurrence. Materials and Methods Analysis was conducted on an institutional review board–approved retrospective data set of 84 deidentified, multi-institutional breast MR examinations from the National Cancer Institute Cancer Imaging Archive, along with clinical, histopathologic, and genomic data from The Cancer Genome Atlas. The data set of biopsy-proven invasive breast cancers included 74 (88%) ductal, eight (10%) lobular, and two (2%) mixed cancers. Of these, 73 (87%) were estrogen receptor positive, 67 (80%) were progesterone receptor positive, and 19 (23%) were human epidermal growth factor receptor 2 positive. For each case, computerized radiomics of the MR images yielded computer-extracted tumor phenotypes of size, shape, margin morphology, enhancement texture, and kinetic assessment. Regression and receiver operating characteristic analysis were conducted to assess the predictive ability of the MR radiomics features relative to the multigene assay classifications. Results Multiple linear regression analyses demonstrated significant associations (R2 = 0.25–0.32, r = 0.5–0.56, P < .0001) between radiomics signatures and multigene assay recurrence scores. Important radiomics features included tumor size and enhancement texture, which indicated tumor heterogeneity. Use of radiomics in the task of distinguishing between good and poor prognosis yielded area under the receiver operating characteristic curve values of 0.88 (standard error, 0.05), 0.76 (standard error, 0.06), 0.68 (standard error, 0.08), and 0.55 (standard error, 0.09) for MammaPrint, Oncotype DX, PAM50 risk of relapse based on subtype, and PAM50 risk of relapse based on subtype and proliferation, respectively, with all but the latter showing statistical difference from chance. Conclusion Quantitative breast MR imaging radiomics shows promise for image-based phenotyping in assessing the risk of breast cancer recurrence. © RSNA, 2016 Online supplemental material is available for this article.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F.-A., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E.-M., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,845
A Simple Sequentially Rejective Multiple Test Procedure
(1979) · Scandinavian Journal of Statistics · doi:10.2307/4615733 · Cited by 21,526
Nishimura, R., Osako, T., Nishiyama, Y., Tashima, R., Nakano, M., Fujisue, M., Toyozumi, Y., & Arima, N. (2013) · Oncology · doi:10.1159/000353099 · Cited by 13,166
Comprehensive molecular portraits of human breast tumours
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11412 · Cited by 12,129
Gene expression profiling predicts clinical outcome of breast cancer
van 't Veer, L. J., Dai, H., van de Vijver, M. J., He, Y. D., Hart, A. A. M., Mao, M., Peterse, H. L., van der Kooy, K., Marton, M. J., Witteveen, A. T., et al. (2002) · Nature · doi:10.1038/415530a · Cited by 9,536 · cited 14×
“These include the 70-gene MammaPrint microarray assay (Agendia, Amsterdam, the Netherlands) (3,4), the 21-gene Oncotype DX assay (Genomic Health, Redwood City, Calif) (5–7) for predicting breast cancer recurrence, and the 50-gene PAM50 assay (Prosigna; Nanostring Technologies, Seattle, Wash) (8,9) for identifying clin…”
MethodInfluentialA Gene-Expression Signature as a Predictor of Survival in Breast Cancer
van de Vijver, M. J., He, Y. D., van 't Veer, L. J., Dai, H., Hart, A. A. M., Voskuil, D. W., Schreiber, G. J., Peterse, J. L., Roberts, C., Marton, M. J., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021967 · Cited by 6,488
A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer
Paik, S., Shak, S., Tang, G., Kim, C., Baker, J., Cronin, M., Baehner, F. L., Walker, M. G., Watson, D., Park, T., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041588 · Cited by 6,277
Draper, N. R., & Smith, H. (1998) · Wiley Series in Probability and Statistics · doi:10.1002/9781118625590 · Cited by 5,024
Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes
Parker, J. S., Mullins, M., Cheang, M. C. U., Leung, S., Voduc, D., Vickery, T., Davies, S., Fauron, C., He, X., Hu, Z., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.1370 · Cited by 4,721
Self-citationThe Cancer Imaging Archive (TCIA): Maintaining and Operating a Public Information Repository
Clark, K., Vendt, B., Smith, K., Freymann, J., Kirby, J., Koppel, P., Moore, S., Phillips, S., Maffitt, D., Pringle, M., et al. (2013) · Journal of Digital Imaging · doi:10.1007/s10278-013-9622-7 · Cited by 4,599
Cited by
Radiomics: the bridge between medical imaging and personalized medicine
Lambin, P., Leijenaar, R. T. H., Deist, T. M., Peerlings, J., de Jong, E. E. C., van Timmeren, J., Sanduleanu, S., Larue, R. T. H. M., Even, A. J. G., Jochems, A., et al. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2017.141 · Cited by 5,688
Artificial intelligence in cancer imaging: Clinical challenges and applications
Bi, W. L., Hosny, A., Schabath, M. B., Giger, M. L., Birkbak, N. J., Mehrtash, A., Allison, T., Arnaout, O., Abbosh, C., Dunn, I. F., et al. (2019) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21552 · Cited by 1,846
Self-citationPredicting cancer outcomes with radiomics and artificial intelligence in radiology
Bera, K., Braman, N., Gupta, A., Velcheti, V., & Madabhushi, A. (2022) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-021-00560-7 · Cited by 819
Limkin, E. J., Sun, R., Dercle, L., Zacharaki, E. I., Robert, C., Reuzé, S., Schernberg, A., Paragios, N., Deutsch, E., & Ferté, C. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx034 · Cited by 757
Deep learning in medical imaging and radiation therapy
Sahiner, B., Pezeshk, A., Hadjiiski, L. M., Wang, X., Drukker, K., Cha, K. H., Summers, R. M., & Giger, M. L. (2019) · Medical Physics · doi:10.1002/mp.13264 · Cited by 740
Self-citationAI in Medical Imaging Informatics: Current Challenges and Future Directions
Panayides, A. S., Amini, A., Filipovic, N. D., Sharma, A., Tsaftaris, S. A., Young, A., Foran, D., Do, N., Golemati, S., Kurc, T., et al. (2020) · IEEE Journal of Biomedical and Health Informatics · doi:10.1109/jbhi.2020.2991043 · Cited by 713
Braman, N. M., Etesami, M., Prasanna, P., Dubchuk, C., Gilmore, H., Tiwari, P., Plecha, D., & Madabhushi, A. (2017) · Breast Cancer Research · doi:10.1186/s13058-017-0846-1 · Cited by 632
Giger (2018) · doi:10.1016/j.jacr.2017.12.028 · Cited by 634
Predicting response to cancer immunotherapy using noninvasive radiomic biomarkers
Trebeschi, S., Drago, S. G., Birkbak, N. J., Kurilova, I., Cǎlin, A. M., Delli Pizzi, A., Lalezari, F., Lambregts, D. M. J., Rohaan, M. W., Parmar, C., et al. (2019) · Annals of Oncology · doi:10.1093/annonc/mdz108 · Cited by 566
Zhang, B., Tian, J., Dong, D., Gu, D., Dong, Y., Zhang, L., Lian, Z., Liu, J., Luo, X., Pei, S., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-2910 · Cited by 494
Beyond imaging: The promise of radiomics
Avanzo, M., Stancanello, J., & El Naqa, I. (2017) · Physica Medica · doi:10.1016/j.ejmp.2017.05.071 · Cited by 483
Radiomics in breast cancer classification and prediction
Conti, A., Duggento, A., Indovina, I., Guerrisi, M., & Toschi, N. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.04.002 · Cited by 386
Deep learning with convolutional neural network in radiology
Yasaka, K., Akai, H., Kunimatsu, A., Kiryu, S., & Abe, O. (2018) · Japanese Journal of Radiology · doi:10.1007/s11604-018-0726-3 · Cited by 368
Defining the biological basis of radiomic phenotypes in lung cancer
Grossmann, P., Stringfield, O., El-Hachem, N., Bui, M. M., Rios Velazquez, E., Parmar, C., Leijenaar, R. T., Haibe-Kains, B., Lambin, P., Gillies, R. J., et al. (2017) · eLife · doi:10.7554/elife.23421 · Cited by 365
Peng, H., Dong, D., Fang, M.-J., Li, L., Tang, L.-L., Chen, L., Li, W.-F., Mao, Y.-P., Fan, W., Liu, L.-Z., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-3065 · Cited by 327
Radiogenomics: bridging imaging and genomics
Bodalal, Z., Trebeschi, S., Nguyen-Kim, T. D. L., Schats, W., & Beets-Tan, R. (2019) · Abdominal Radiology · doi:10.1007/s00261-019-02028-w · Cited by 310
Saha, A., Harowicz, M. R., Grimm, L. J., Kim, C. E., Ghate, S. V., Walsh, R., & Mazurowski, M. A. (2018) · British Journal of Cancer · doi:10.1038/s41416-018-0185-8 · Cited by 310
Geras, K. J., Mann, R. M., & Moy, L. (2019) · Radiology · doi:10.1148/radiol.2019182627 · Cited by 295
From Handcrafted to Deep-Learning-Based Cancer Radiomics: Challenges and Opportunities
Afshar, P., Mohammadi, A., Plataniotis, K. N., Oikonomou, A., & Benali, H. (2019) · IEEE Signal Processing Magazine · doi:10.1109/msp.2019.2900993 · Cited by 294
Park, J. E., Kim, D., Kim, H. S., Park, S. Y., Kim, J. Y., Cho, S. J., Shin, J. H., & Kim, J. H. (2020) · European Radiology · doi:10.1007/s00330-019-06360-z · Cited by 282
Precision medicine and radiogenomics in breast cancer: new approaches toward diagnosis and treatment
Pinker, K., Chin, J., Melsaether, A. N., Morris, E. A., & Moy, L. (2018) · Radiology · doi:10.1148/radiol.2018172171 · Cited by 275
Self-citationTruhn, D., Schrading, S., Haarburger, C., Schneider, H., Merhof, D., & Kuhl, C. (2019) · Radiology · doi:10.1148/radiol.2018181352 · Cited by 273
Rapid review: radiomics and breast cancer
Valdora, F., Houssami, N., Rossi, F., Calabrese, M., & Tagliafico, A. S. (2018) · Breast Cancer Research and Treatment · doi:10.1007/s10549-018-4675-4 · Cited by 258
Tracking tumor biology with radiomics: a systematic review utilizing a radiomics quality score
Sanduleanu, S., Woodruff, H. C., de Jong, E. E. C., van Timmeren, J. E., Jochems, A., Dubois, L., & Lambin, P. (2018) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2018.03.033 · Cited by 242
“[17] MR BC Core biopsy assessment of expression of ER, PR, HER2.”
Role of imaging in the era of precision medicine
Giardino, A., Gupta, S., Olson, E., Sepulveda, K., Lenchik, L., Ivanidze, J., Rakow-Penner, R., Patel, M. J., Subramaniam, R. M., & Ganeshan, D. (2017) · Academic Radiology · doi:10.1016/j.acra.2016.11.021 · Cited by 87
Jansen, R. W., van Amstel, P., Martens, R. M., Kooi, I. E., Wesseling, P., de Langen, A. J., Menke-Van der Houven van Oordt, C. W., Jansen, B. H. E., Moll, A. C., Dorsman, J. C., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.24893 · Cited by 63
Radiogenomics for Precision Medicine With a Big Data Analytics Perspective
Panayides, A. S., Pattichis, M. S., Leandrou, S., Pitris, C., Constantinidou, A., & Pattichis, C. S. (2019) · IEEE Journal of Biomedical and Health Informatics · doi:10.1109/jbhi.2018.2879381 · Cited by 66
Zhang, Y., Lobo-Mueller, E. M., Karanicolas, P., Gallinger, S., Haider, M. A., & Khalvati, F. (2021) · Scientific Reports · doi:10.1038/s41598-021-80998-y · Cited by 62
Wu, J., Li, X., Teng, X., Rubin, D. L., Napel, S., Daniel, B. L., & Li, R. (2018) · Breast Cancer Research · doi:10.1186/s13058-018-1039-2 · Cited by 53
Hesso, I., Kayyali, R., Dolton, D.-R., Joo, K., Zacharias, L., Charalambous, A., Lavdaniti, M., Stalika, E., Ajami, T., Acampa, W., et al. (2023) · Radiation Oncology · doi:10.1186/s13014-023-02351-z · Cited by 33
Metadata
- Authors
- Li, H., Zhu, Y., Burnside, E. S., Drukker, K., Hoadley, K. A., Fan, C., Conzen, S. D., Whitman, G. J., Sutton, E. J., Net, J. M., Ganott, M., Huang, E., Morris, E. A., Perou, C. M., Ji, Y., & Giger, M. L.
- Venue
- Radiology
- Published
- 2016-11
- Volume
- 281
- Issue
- 2
- Pages
- 382-391
- ISSN
- 0033-8419 (ISSN-L)
- 1527-1315
- OpenAlex
- W2346265746
- Cited by
- 461
- References
- 40
- FWCI
- 40.74
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.